Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Paxlovid
Pharma
Pfizer cranks up revenue outlook amid Paxlovid sales bump
The company is projecting yearly sales of $61 billion to $64 billion in a $1.5 billion boost from previous forecasts.
Zoey Becker
Oct 29, 2024 10:40am
Dupixent takes pharma DTC top spot in September
Oct 7, 2024 10:00am
FDA blesses Pfizer with priority review voucher for Paxlovid nod
May 24, 2024 2:04pm
Shionogi's antiviral comes up short in global COVID-19 trial
May 13, 2024 10:48am
Pfizer to establish a direct-to-consumer online platform
May 1, 2024 11:22am
In Pfizer's trying year, CEO takes 35% pay cut to $21.6M
Mar 15, 2024 9:09am
